Abstract. Two neuropeptides, neuropeptide B (NPB) and prolactin-releasing peptide (PrRP), have been suggested to play important roles in control of the hypothalamic-pituitary-adrenal (HPA) axis in rodents. The aim of the present study was to clarify the central actions of NPB or PrRP in sheep. Ovariectomized ewes were surgically implanted with a cannula directed to the lateral ventricle. They received intracerebroventricular (icv) administration of 400 μl of artificial cerebrospinal fluid, NPB (0.05, 0.5 or 5 nmol), PrRP (0.5, 5 or 50 nmol) or corticotropin-releasing hormone (CRH, 0.5 or 5 nmol) through the cannula, and blood samples were taken 30 and 0 min prior to and 15, 30, 60 and 90 min after the injection. Cortisol concentrations in plasma were determined by enzyme immunoassay. Administration of 0.5 nmol NPB resulted in a significant increase in the cortisol concentration compared with the vehicle control, whereas the cortisol concentration after lower or higher doses of NPB did not differ from the control value. Thus, an icv injection of NPB produced a bell-shaped dose-response of cortisol concentration. Administration of PrRP had no significant effect on the cortisol concentrations at any dose examined. Icv injection of CRH dose-dependently increased plasma cortisol concentrations. These results demonstrate that central NPB stimulates cortisol secretion, suggesting that this neuropeptide plays some roles in control of the HPA axis in sheep. On the other hand, unlike its role in rodents, PrRP is unlikely to be involved in control of the HPA axis in this species. Key words: Corticotropin-releasing hormone (CRH), Cortisol, Neuropeptide B (NPB), Prolactin-releasing peptide (PrRP), Sheep (J. Reprod. Dev. 54: [138][139][140][141] 2008) ctivation of the hypothalamic-pituitary-adrenal (HPA) axis, which culminates in secretion of glucocorticoids from the adrenal grand, is vital for stress response. Glucocorticoids stimulate gluconeogenesis in the liver and inhibit synthesis of inflammation-mediating substances, such as prostaglandins, thromboxanes and leukotrienes, as stress-induced defensive responses [1] . On the other hand, activation of the HPA axis suppresses reproductive functions through the action of glucocorticoids and the central mechanism regulating the HPA axis [2] . Activation of corticotropin-releasing hormone (CRH) neurons in the paraventricular hypothalamic nucleus (PVN) inhibits pulsatile luteinizing hormone (LH) secretion, which results in reduced gonadal activity [3, 4] . Furthermore, inhibition of pulsatile LH secretion has been shown to be enhanced by noradrenergic input into the PVN from the brainstem [5] or input into the bed nucleus of the stria terminalis [6] . Thus, clarification of the central mechanism regulating the HPA axis might help to further understand control of reproductive functions.
(J. Reprod. Dev. 54: [138] [139] [140] [141] 2008) ctivation of the hypothalamic-pituitary-adrenal (HPA) axis, which culminates in secretion of glucocorticoids from the adrenal grand, is vital for stress response. Glucocorticoids stimulate gluconeogenesis in the liver and inhibit synthesis of inflammation-mediating substances, such as prostaglandins, thromboxanes and leukotrienes, as stress-induced defensive responses [1] . On the other hand, activation of the HPA axis suppresses reproductive functions through the action of glucocorticoids and the central mechanism regulating the HPA axis [2] . Activation of corticotropin-releasing hormone (CRH) neurons in the paraventricular hypothalamic nucleus (PVN) inhibits pulsatile luteinizing hormone (LH) secretion, which results in reduced gonadal activity [3, 4] . Furthermore, inhibition of pulsatile LH secretion has been shown to be enhanced by noradrenergic input into the PVN from the brainstem [5] or input into the bed nucleus of the stria terminalis [6] . Thus, clarification of the central mechanism regulating the HPA axis might help to further understand control of reproductive functions.
Neuropeptide B (NPB) and prolactin-releasing peptide (PrRP) are neuropeptides identified as endogenous ligands for orphan Gprotein-coupled receptors (GPR), GPR7 and hGR3/GPR10, respectively [7, 8] . It has been shown that NPB mRNA is detectable in the rat and mouse brain, with the highest expression occurring in the hypothalamus and hippocampus [7] , and that the mRNA of its receptor, GPR7, is abundantly expressed in the amygdala, hypothalamus and pituitary [7, [9] [10] [11] . In the rat, PrRP-producing neurons exist in the dorsomedial hypothalamic nucleus, the nucleus of the solitary tract and the ventrolateral reticular formation of the medulla oblongata [12] [13] [14] [15] [16] . These PrRP-producing neurons send their axons to a wide range of brain areas, including the PVN [15, 17] , in which PrRP binding sites [16] or GPR10 mRNA [18] have been shown to exist in the rat. Pharmacological studies have revealed that an intracerebroventricular (icv) injection of NPB sign i f i c a n t l y i n c r e a s e s t h e p l a s m a c o n c e n t r a t i o n s o f adrenocorticotrophic hormone (ACTH), corticosterone and prolactin in the rat [19] . An icv injection of PrRP also stimulates prolactin [20] , ACTH and β-endorphin secretion through a CRHmediated mechanism in the rat [17] . Furthermore, it has been demonstrated that various types of stress, such as restraint and footshock, activate c-Fos accumulation in PrRP neurons in the medulla oblongata in the rat [21] [22] [23] .
These accumulating lines of evidence in the rodent suggest that both NPB and PrRP play important roles in the neuroendocrine system, especially in regulating the HPA axis. However, little is known about their roles in domestic animals. Therefore, in the present study, the effects of icv administration of these peptides on cortisol secretion were examined in ovariectomized (OVX) ewes in order to clarify the central actions of NPB and PrRP in the HPA axis.
Materials and Methods

Animals and surgery
Five adult OVX Corriedale ewes (45-55 kg) maintained at the National Institute of Livestock and Grassland Science were used in the present study. The ewes were implanted with an 18-gauge stainless steel guide cannula directed to the lateral ventricle (LV) for the icv injection, according to a method developed for the goat [24] . In brief, under halothane anesthesia, the head of each ewe was fixed in a stereotaxic frame (Narishige, Tokyo, Japan), and a small hole was drilled in the skull 4.0-6.0 mm rostral to the bregma and 3 mm lateral to the midline. With the aid of a radioventriculograph, the guide cannula was inserted so that the tip was directed to Monro's foramen and positioned 5 mm above the LV. The guide cannula was then fixed to the skull and fitted with a 21-gauge stylet to prevent occlusion. After surgery, the ewes were loosely tied to individual stanchions and maintained in an experimental room under controlled conditions (23 ± 2 C, 24 h lights on). The ewes were fed a standard mashed diet and hay wafer once daily at 1100 h and had free access to water and supplemental minerals. Prior to the experiment, the animals were conditioned to the icv injection procedure.
All experimental procedures were approved by the Committee on the Care and Use of Experimental Animals of the National Institute of Agrobiological Sciences.
Experimental design
One day before the experiment, a jugular catheter was fitted to the OVX ewes for blood sampling. They received an icv administration of 400 μl of artificial cerebrospinal fluid (aCSF; 125 mM NaCl, 2.5 mM KCl, 0.5 mM NaH2PO4, 1.2 mM Na2HPO4, 1.2 mM CaCl2, 1.0 mM MgCl2 and 27 mM NaHCO3) [25] , bovine PrRP (0.5, 5 and 50 nmol; Ana Spec, San Jose, CA, USA) or bovine NPB (0.05, 0.5 and 5 nmol; Phoenix Pharmaceuticals, Belmont, CA, USA) through an injection cannula 5 mm longer than the guide cannula. The order of the treatment was randomized within the animals. In addition, ovine CRH (0.5 and 5 nmol; Ana Spec), which stimulates cortisol secretion in this species [26] , was also injected into four OVX ewes to compare the efficacy of the action. The injection took 1 min, with the injection cannula remaining in place for another 1 min. Each icv injection was carried out at 1400 h to avoid the influence of circadian fluctuations of cortisol secretion and was separated from the previous injection by at least 2 days. Blood samples (2 ml) were taken 30 and 0 min prior to and 15, 30, 60 and 90 min after the injection. The blood was centrifuged, and the plasma was stored at -30 C until determination of cortisol concentrations.
Assay
Plasma cortisol concentrations were quantified in duplicate using an enzyme immunoassay as described previously [27] . In 
Data analysis
For statistical analysis, the area under the curve (AUC) of the cortisol concentration was calculated from 0 to 90 min after icv injection in each animal, and a mean AUC was calculated for each treatment group. Statistical differences in mean values between control (aCSF) and treatments were analyzed using the Dunnett test for multiple comparisons with the JMP statistics software (SAS Institute, Cary, NC, USA). Figure 1 shows the time-course changes in the plasma cortisol concentration when OVX ewes received icv injections of aCSF or several doses of NPB, PrRP or CRH. No change was observed in the plasma cortisol concentrations after injection of aCSF, indicating that the influence of stress from the icv injection procedure was negligible. The low dose (0.05 nmol) of NPB did not affect the plasma cortisol concentration. After administration of the middle dose (0.5 nmol) of NPB, the plasma cortisol concentration began to increase and reached a peak value at 60 min. On the other hand, with the high dose (5 nmol) of NPB administration, although the plasma cortisol concentration increased slightly at 15 min, it declined towards the basal level thereafter. The plasma cortisol concentration did not change after icv injections of PrRP at any dose (0.5, 5 and 50 nmol). After administration of 5 nmol of CRH, the plasma cortisol concentration rapidly rose and reached a peak value 30 min after the injection.
Results
To statistically compare the effect of icv injections of peptides on cortisol secretion, AUCs of the cortisol concentrations were calculated (Fig. 2) . The mean AUC for the 0.5 nmol NPB treatment was significantly larger than that of the vehicle treatment (P<0.05, Dunnett test). Although the mean AUCs for the 0.05 and 5 nmol NPB treatments were slightly larger than that of the control, the differences were not statistically significant. Thus, the centrally administered NPB resulted in a bell-shaped dose-response of cortisol secretion in the ewe. PrRP had no effect on cortisol secretion. Even with an injection as high as 50 nmol of PrRP, the mean AUC was not different from that of the control value. Icv administration of CRH resulted in a dose-dependent increase in cortisol secretion, and the mean AUC of the 5 nmol CRH treatment was significantly larger than that of the vehicle treatment (P<0.05).
Discussion
In the present study, we demonstrated that an icv administration of 0.5 nmol of NPB significantly increased the plasma cortisol concentration, suggesting that NPB is involved in control of the HPA axis in sheep. The fact that mRNA for GPR 7, a major subtype of NPB receptors, has been shown to be distributed in the pituitary as well as in a wide range of brain areas [7, [9] [10] [11] suggests that the pituitary is one of the possible sites of NPB action to stimulate cortisol secretion. It has been suggested that centrally administered CRH acts directly on the pituitary and increases ACTH and thus cortisol secretions in sheep [26] . However, NPB had no effect on the release of ACTH in an in vitro study using rat pituitary cells [19] . Moreover, the stimulatory effects of NPB on ACTH or corticosterone secretions have been found to be attenuated by pretreatment with an anti-CRH antibody in the rat [19] . Therefore, the action of NPB, unlike that of CRH, might be exerted in the central nervous system. Among several brain areas, the medial nucleus of the amygdala (MeA) expresses the highest levels of GPR7 mRNA and binding signals of radiolabeled NPB in the rat [9, 10] . Furthermore, it has been demonstrated that a large population of neurons in the MeA projects to the PVN [28, 29] and that electrical stimulation of the MeA can increase corticosterone secretion in the rat [30] . Therefore, this nucleus is a likely candidate for the site of NPB action to activate the HPA axis. It is also possible that NPB acts on the PVN to activate the HPA axis. The PVN has also been shown to express GPR7 mRNA and binding signals of radiolabeled NPB, although their levels are low [9, 10] .
The present results showing that central NPB in sheep activates the HPA axis is comparable with that obtained in the rat [19] . However, the response pattern of the HPA axis seems to differ between the two species. After icv administration of NPB, the plasma corticosterone concentration increases in a dose-dependent manner in the rat [19] , whereas we observed a bell-shaped doseresponse for the plasma cortisol concentration in the sheep. Although the reason for this species difference is unclear at present, it is possible that another type of NPB receptor is involved in the NPB action in sheep. Although NPB was initially identified as a ligand of GPR7 [7] , a subsequent study demonstrated that it also bound to GPR8 [31] . It is noteworthy that GPR8 is not expressed in rodents, while both GPR7 and GPR8 are highly conserved in other species [10] . GPR7 and GPR8 share 70% nucleotide and 64% amino acid identities with each other [11] , and GPR8 is hypothesized to have originated as a replicate of GPR7 after the divergence of rodents from the evolutionary lines leading to humans, lemurs, tree shrews and rabbits [10] . Because NPB has been shown to bind and activate human GPR7 or GPR8 with median effective concentrations of 0.23 nM and 15.8 nM, respectively [31] , it is plausible to conclude that, at a high dose, NPB activates not only GPR7 but also GPR8. Although the physiological function of GPR8 is mostly unknown at present, given that activation of GPR8 induces an inhibitory impact on cortisol secretion, a bell-shaped dose-response of cortisol secretion would be expected, as shown in the present study.
We did not observe any effect of the icv injections of PrRP on the plasma cortisol concentrations in sheep. It is unlikely that absence of a plasma cortisol response to PrRP is due to the experimental design in the present study. Though we used commercially available bovine PrRP in sheep, this could not have affected the result, since the amino acid sequence of PrRP is identical between cattle and sheep [32] . The use of OVX ewes also does not explain this result, since it has been demonstrated that the cortisol response to stress is higher in the OVX ewe than in the estradiol-treated OVX ewe [33] . We centrally injected as high as 50 nmol PrRP. It remains possible that much higher doses of PrRP may be effective in sheep. However, it should be noted that, in comparison, low doses of NPB (0.5 nmol) or CRH (5 nmol) triggered significant effects on the plasma cortisol concentration in the present study. Consequently, the present result suggests that central PrRP does not participate in control of the HPA axis in sheep. Curlewis et al. [32] found that PrRP mRNA is abundantly expressed in the ventromedial hypothalamus and brainstem of sheep. However, they also failed to observe any change in the plasma prolactin concentration after an icv injection of 50 nmol of PrRP in sheep [32] . Clearly, further studies are required to determine the physiological role of central PrRP in this species.
In conclusion, the present study demonstrated that icv administration of NPB increased the plasma cortisol concentration in a bell-shaped dose-response manner, suggesting that central NPB plays some roles in control of the HPA axis in sheep. On the other hand, since icv administration of PrRP had no effect on the plasma cortisol concentration, this peptide is unlikely to be involved in control of the HPA axis in this species.
